Associated with doesn't entail cause.
Firemen are
often found at fires; that doesn't prove they cause fires. Kidney damage
is associated with hypertension, not caused by it. That is because
hypertension is caused by atherosclerosis (stiff, swollen arteries full of
plaque that contains fibrous cells, lipids, lymphocytes, and calcium). But instead
of treating atherosclerosis that
causes the ischemic events, pharma treats hypertension. It is like
treating fever instead of the flu.
Ischemia (ischemic
events) occurs when there is a restriction of
the blood supply causing a shortage of oxygen and glucose needed for cellular
metabolism to keep the tissue alive. It
can be caused by vasoconstriction, embolism, or thrombosis. The first two account
for less than 10% of
those events. The third, thrombosis, is
caused almost entirely by young soft plaque leaking from an artery interior
wall and this leaked plaque can cause by blocking supply of blood the destruction
of tissue. If the thrombosis caused
ischemic events occur in the heart and destroys sufficient muscle it is called
a myocardial fraction (heart attack), destroys sufficient neuron a stroke. These
events can occur in arterioles (small
arteries) and be subclinical events.
Thus an angina pain could be a small ischemic event. And some bouts of
disorientation are caused
by mini-ischemic events in the brain.
Often these mini-events go unnoticed.
However if they occur frequently in the brain (where there is no pain
receptors) it causes the second most common form of dementia, vascular
dementia. If these mini-ischemic events
occur often enough in the kidney, it causes kidney dysfunction. And the same
occurs in other tissues; of note
is the eyes, bowels, limbs, under the skin, but not limited to these
tissues.
Because of their
side effects, to treat hypertension with drugs
causes more problems than it prevents. Based
on industry funded studies (which have Positive bias by design—see Prof. Prof. Ben
Goldacre’s Bad Phama) the
reduction
in major coronary events using pharm short-term studies is at best is not statistically
significant for beta
blockers, ACE
inhibitors , Angiotensin
II receptor antagonists, and calcium
channel blockers, so found the
prestigious Cochrane Review and Worst Pill, and thus negative when side effects
are considered. But doctors don’t know
enough about the biology behind the processes of hypertension because their
medical textbooks and continuing education is written and given by pharma’s
KOLs (key opinion leaders), and they rely on-pharma generated guidelines for
clinical decisions, thus they treat the sign of atherosclerosis, hypertension,
with drugs rather than the causes of atherosclerosis.
The web of deceit
on causes of coronary events has been carefully
woven: hypercholesterolemia is another
bystander. It is only very weekly
associated with coronary
events. For example the Framingham Study
found that the elderly with high cholesterol had less coronary events and lived
longer than those with low cholesterol (Prof. Uffe
Ravnskov, Ignoring the Awkward!
p 36). The surrogate outcome of statins lowering
cholesterol is not associated with fewer ischemic events, and their side
effects are significant. Yet Braunwald’s
cardiology textbook repeats the mantra that “statins
are safe and effective.” Unfortunately,
for doctors and the public pharma
frames the discussion of cardiovascular disease. It is for the sales of drugs—as
Prof. Peter
Gotzsche states below.
Even those who know better, they avoid this
topic or give it lip-service rather than lose their audience. Thus the chorus
of critics of the cholesterol
hypothesis is small, but their evidence convincing.
It is as Prof.
Peter Gotzsche wrote:
“Whatever the industry
does, whatever it calls it, and whatever it says about its noble motives, it
all boils down to one thing: selling
drugs. “ Deadly Medicines and Organised
Crime: how big pharma has corrupted
healthcare p. 87. Most of what pharma
writes is through KOLs. To be a KOL
entails receiving large sums for services to pharma. More
complete is the statement by Dr. Evens in The
Guardian: “The pharmaceutical
industry is the
most lucrative, the most cynical and the least ethical
of all the industries. It is like
an octopus with tentacles that has infiltrated all
the decision-making bodies: World
Health Organizations,
government agencies, parliaments, high administrations in health and hospitals
and the medical profession." He
is the author
of "The Guide to the 4,000 Useful, Useless
or Dangerous Medicines" (Sept 2012), with Dr. Bernard Debre is director of the prestigious Necker Institute;
Dr.
Philippe Even is a member
of the French Parliament. F.
Pharma. It is as Prof. Marcia Angell,
Harvard: states: “The 800 pound
gorilla can do whatever it wants” (referring to the $800 billion dollar
industry). Her
excellent 77
minute lecture on pharma proves the quotes above. It is at https://www.youtube.com/watch?v=ZqKY6Gr6D3Q.
From
my email response to a friend’s
phone call about a doctor’s visit (10/9/15):
Thanks for telling me how your doctor is selling the high-blood pressure
medications. It is helpful to me to
learn how doctors sell pharma's drugs. They sell the benefits and hide
the side effects (assuming they have been informed adequately about them). Thus
you were told that hypertension causes
heart attacks and kidney dysfunction in your visit yesterday. Pharma’s
sales pitch has two flaws: biological and results of treatment. So
put your thinking cap on and follow my
evidenced base account of the complex web of biological & results deceptions.
What
you and nearly every person
over the age of 60 get following a physical is a strong recommendation from
their physician to treat with a drug some putative
sign of cardiovascular disease.
What I wish to convey to you is that with very few exceptions these
drugs are treating symptoms rather than the underlying causal condition. Treating
signs is not effective, and thus not
worth their side effects. I have spent
11 years since healthfully.org was born looking into medical issues and the
methods of pharma. Moreover I have been
reading medical literature since 1972 and came to it with a strong science background. I am warning you about the bullshit based upon
tobacco science that pharma teaches
physicians, and I will also presenting to you what medical science has uncovered
concerning cardiovascular
disease. It
is as Prof. Peter
Gotzsche
wrote:
“Whatever the industry
does, whatever it calls it, and whatever it says about its noble motives, it
all boils down to one thing: selling
drugs.“ Deadly Medicines and Organised
Crime: how big pharma has corrupted
healthcare p. 87. His book
meticulously adds flesh to how big pharma has corrupted healthcare.
4) In what follows
I will show you how much big pharma has
corrupted the science behind cardiovascular disease for to sell their drugs. I
will start with hypertension (your concern
Danny), then hypercholesterolemia, followed by endothelial dysfunction and end
with the major causes for atherosclerosis and thus cardiovascular disease. You
will arrive at where you started and know the healthful path for the first
time.
Associated with doesn't entail cause.
Firemen are
often found at fires; that doesn't prove they cause fires. Kidney damage
is associated with hypertension, not caused by it. That is because
hypertension is caused by atherosclerosis (stiff, swollen arteries full of
plaque that contains fibrous tissue, lipids, lymphocytes, and calcium). When
plaque leaks it can damage the
kidneys. But instead of treating
atherosclerosis that causes the ischemic events, pharma treats hypertension.
It is like treating fever instead of the flu.
Ischemia (ischemic events)
occurs when there is a restriction of the blood
supply causing a shortage of oxygen and glucose needed for cellular metabolism
to keep the tissue alive. It can be
caused by vasoconstriction, embolism, or thrombosis. The first two account for
less than 10% of
those events. The third, arterial thrombosis
is caused almost entirely by young soft plaque before a hard fibrous cap forms
over the plaque. It leaks through the
endothelial cells that line the artery, and this leaked plaque can block the
flow of blood to cause the destruction of tissue. If the thrombosis-caused ischemic
events
occur in the heart and destroys sufficient muscle it is called a myocardial fraction
(heart attack, MI); destroys sufficient
neuron a stroke. These events can
block arterioles (small arteries)
and result in subclinical events. Thus
an angina pain could be a small ischemic event; and some bouts of mental disorientation
could be mini-ischemic events. Often
these mini-events go unnoticed. If they
occur frequently in the brain (where there are no pain receptors) it causes the
second most common form of dementia, vascular dementia. If these mini-ischemic
events occur often
enough in the kidney, it causes kidney dysfunction. And the same occurs in other
tissues; of note
is the eyes, bowels, limbs, under the skin, but not limited to these
tissues. Leaking plaque is caused
by atherosclerosis,
not hypertension. Thus as expected
lowering blood pressure doesn’t significantly lower the frequency of
events—though pharma claims it does. So
what are we to make of pharma’s claims?
First the FDA permits
the surrogate outcome of lower blood
pressure; but we take antihypertensive drugs to prevent major events. Second
to avoid negative results very, very
few pharma-funded studies use as endpoints just
deaths and heart attacks.[1] This claim of benefits is based on industry
funded studies (which have Positive bias by design and gross manipulation of results—see Prof.
Prof. Ben
Goldacre’s Bad
Phama). Even so these shoddy short-term studies by
pharma (what I call tobacco science)
do NOT result in a statistically significant
reduction of major coronary events for beta
blockers, ACE
inhibitors , Angiotensin
II receptor antagonists, and calcium
channel blockers,
so found the prestigious Cochrane Review
and Worst Pill; thus these drugs are
not worth their side effects.[2] The worst of these pharma studies (not used
by Cochrane and Worst Pill in their analysis) are used to market these drugs
and justify treatment guidelines. What
we know about antihypertensive drugs and pharma, this is their business
model—“all about sales”.
8) The web of deceit
on causes of coronary events has been
carefully woven: hypercholesterolemia is
another bystander. High cholesterol is
only very weakly associated with
coronary events. For example the
Framingham Study found that the elderly with high cholesterol had less coronary
events and lived longer than those with low cholesterol (Prof. Uffe Ravnskov, Ignoring
the Awkward! p 36). The surrogate outcome of statins lowering cholesterol
is not associated with fewer ischemic events, and their side effects are
significant. Yet Braunwald’s cardiology textbook
repeatedly states the industry’s mantra that “statins are safe and effective.”
For the doctors and the public, pharma frames the discussion of
cardiovascular disease. It is all for
the sales of drugs as Prof. Peter
Gotzsche states. Even
those who
know avoid this topic or give it lip-service rather than lose their
audience. Thus the chorus of critics of
the cholesterol hypothesis is small, but their evidence convincing. Enter in
the Amazon website cholesterol
myth and you will find over 50 books thereon.
So what is driving the development
of atherosclerosis and thus myocardial fractions? Endothelia cells are the gatekeepers for what
enters the tissues that make up the arteries.
Thus damage to them--termed endothelial dysfunction-- promotes the entering of
substances into the artery tissue that cause atherosclerosis. Endothelia
dysfunction has 5 main
causes: 1) high level of blood sugar
especially the 7 times more reactive fructose (thus heart attacks are
associated with diabetes and the Western diet) through the process of glycation,[3]
which damages the endothelial cells. 2)
Fructose
is converted to fat in the liver. Too
much fructose with too little exercise results in a fatty liver.
A fatty liver mucks up the metabolic
regulatory system to cause insulin resistance
and thus weight gain. Among its
many
effects is a higher level of blood sugars; thus through glycation damages
endothelial cells. 3) A diet high
in
trans-fats and polyunsaturated fats (polyunsaturated fats are subject to a
process of rancidification in the body and on the shelf). Their abnormal shapes adversely affect the
cell walls of the endothelial cells. 4)
Carbon
monoxide and other reactive chemical in the blood which can bond to the
endothelial cells (similar to fructose and glucose). 5) Infectious agents through their toxins circulating
in the blood damage the endothelial cells and thereby permit the penetration of
pathogens into the tissue within the arteries.
Infectious agents in the artery walls have been clearly shown to be the major cause of plaque formation
through an immune response to their presence.[4] In conclusion, the five processes which
damage the endothelial cells are atherogenic.
Young immature plaque is
similar to a boil, both are caused by infection. When
the young plaque leaks it can cause a
thrombosis. Evidence for the role
of
pathogens goes back over 100 years: “There is every indication that the production
of tissue in the intima [inner layers of artery wall] is the result of a direct
irritation of that tissue by presence of infection or toxins.”[5] There are hundreds of published journal
articles, see these links and, or enter into Google
scholar and enter atherosclerosis + pathogens.
Similarly articles prove the other causes:
enter glycation + endothelial dysfunction,
trans-
fats + endothelial dysfunction, and rancid + polyunsaturated fats.[6] Thus we can see that the Western diet
with
its unhealthy fats, refined carbohydrates and loads of sugars (US average is
151 pounds) which lead to metabolic dysfunction resulting in insulin resistance
and fatty
liver disease, and cigarettes are driving forces in endothelial
dysfunction. Thus to reduce the
risk of
atherosclerosis and its comorbidities, we must reduce the risk for endothelial
cell damage.
We have as problems not
just the high sugar (fructose being the worst sugar), but also another example
of profits before health.
Polyunsaturated fats are cheap, so too is their conversion to saturated
fats by hydrogenation to improve the flavor of foods—a byproduct are
trans-fats. These fats are favored
by
food manufacturers, thus the widely held belief that they are healthful, and
the more expensive saturated fats are unhealthful. It turns out that the expensive saturated
fats and monounsaturated fats are the best for health—see fats for the very convincing
evidence. And it get worse, the
transfats made from these polyunsaturated fats through a process of
hydrogenation have been proven to promote cardiovascular disease.
A number of countries have totally banned
them, the US has created exclusion for business and then doesn’t inforce the labeling
requirement but relies upon the food manufacturer to inform the public of their
presence. Again the saying of Prof.
Gotzsche
rings true: “it all boils
down to one
thing, the selling of drugs” or in this case that of the cheaper
polyunsaturated fats and the hydrogenated fats derived therefrom.
In a system which measures performance by
profits, it is more profitable to manipulate beliefs than to do the right
thing.
Like so much else, the
popular “wisdom” on diet fails—as proven by the current pandemics.
I have spent 2 years (10-2013 to 10-2015)
examining the obesity and diabetes pandemics and their role in promoting cardiovascular
disease. The main cause of these
conditions is diet, and thus the main fix and prevention lies with diet.
I have arrived at an evidenced based dietary
fix for preventing and reversing endothelial dysfunction, insulin resistance
and fatty liver disease--click
on link and long version. The regulatory
and information systems are
broken.
Most of what pharma
writes is through KOLs
(key
opinion leaders). To be a KOL
entails receiving large sums for services to pharma—not employees. In
our corporatist world, the 800 pound
gorilla can do pretty much anything it wants” as Harvard Prof Marcia
Angell
states (a reference to the $800
billion industry). More complete is the statement by Dr. Evens
in The Guardian: “The
pharmaceutical industry is the most lucrative, the most cynical and the least ethical of all the industries. It is like
an octopus with tentacles that has infiltrated all
the decision-making bodies: World Health Organizations,
government agencies, parliaments, high administrations in health and hospitals
and the medical profession." He
is the author
of "The Guide to the 4,000 Useful, Useless
or Dangerous Medicines" (Sept 2012), with Dr. Bernard Debre is director of the prestigious Necker Institute;
Dr.
Philippe Even is a member
of the French Parliament--F. Pharma.
Prof. Angell’s 77 minute lecture confirms these quotes, at https://www.youtube.com/watch?v=ZqKY6Gr6D3Q.
For more on
hypertension, http://healthfully.org/rl/id1.html, atherogenesis http://healthfully.org/rl/id2.html and
http://healthfully.org/rl/id8.html, high dose aspirin
treatment http://healthfully.org/rc/id17.html and dietary treatments http://healthfully.org/rh/id12.html of atherosclerosis (the
high sugar Western diet causes endothelia
dysfunction which is causally
associated with atherosclerosis), and for the cholesterol myth watch the
Australian Broadcast corporation at https://www.youtube.com/watch?v=Sa9ZYsW59Zo, and on my website are
numerous articles on statins, the cholesterol myth, the major causes for
atherosclerosis. They can be found
through the Google-internal search engine on each home page--one article on the
cholesterol myth is at http://healthfully.org/rl/id5.html.
[1] It is actually
much worse than that. “The
aim of drug regulation is to ensure that only effective and safe treatments
reach patients. Ideally, regulatory decisions are based on good quality data
from large trials measuring real world, patient centred outcomes. Licensing
agencies, however, routinely approve treatments on the basis of small placebo
controlled trials evaluating short term, surrogate endpoints in selected populations.
Consequently, medicines are commonly prescribed without good quality data on
their long term benefits and harms. Current
licensing standards are inadequate to predict the real world therapeutic value
of new medications.”
Sept 9, 2015, British medical Journal, Dr.
Huseyin Naci http://www.bmj.com/content/351/bmj.h5260?etoc=
[3] Glycation is the
non-enzymatic bonding of
sugars to lipids and proteins. This
bonding is damaging to the endothelial cells that line the arteries—more so
than to the short-lived red and white blood cells.
[4]
Pharma with their tobacco science claims that atherosclerosis is caused by
damage LDL that causes an immune response.
This is far fetch (see Ravnskov supra) are click on link. LDL not only transports cholesterol and fat,
it also functions as part of the immune system.
That is why it is found in plaque.
Numerous journal articles make both points; click on this link and for a few of the published
journal articles. Thus we have 2
distortions, that concerning pathogens and that on the function of LDL.
[5]
Klotz O, Manning Mf, Journal of Pathol Bacteriol, 1911;16:211-220.
[6]
Trans and oxidize polyunsaturated fats are unnatural, thus our body lacks the
enzymes to metabolize them. Fats
are
also utilized in the formation of cell walls.
The incorporation of these abnormal fats in the walls adversely affects
the functions of endothelial cells. This
is particularly significant with endothelial cells in the arteries and
arterials in that they act as gatekeepers for the entrance through active
transport of chemical, lymphocytes, bacteria, cholesterol, and other substances
into the underlying tissues. Thus
these
abnormal cells promote through the penetration of pathogens which casue the
immune process leading to atherosclerosis.
This damage to the cells also occurs through glycation (sugar bonding to
endothelial cells) and reactive chemicals such as carbon monoxide from
cigarettes. This explains why diabetes
doubles the risk of heart attacks, as does the long-term smoking.
|